UNICA IRIS Institutional Research Information System

BALBONI, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 155.447
NA - Nord America 13.582
AS - Asia 5.700
SA - Sud America 891
AF - Africa 136
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 6
Totale 175.787
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 152.106
US - Stati Uniti d'America 13.446
SG - Singapore 2.272
CN - Cina 1.854
UA - Ucraina 981
BR - Brasile 695
SE - Svezia 663
VN - Vietnam 494
GB - Regno Unito 424
FI - Finlandia 405
DE - Germania 303
FR - Francia 302
HK - Hong Kong 288
IN - India 195
KR - Corea 125
RU - Federazione Russa 71
BD - Bangladesh 70
CA - Canada 70
AR - Argentina 66
IQ - Iraq 51
MX - Messico 42
JP - Giappone 40
ID - Indonesia 35
NL - Olanda 34
PK - Pakistan 32
CO - Colombia 31
MA - Marocco 31
VE - Venezuela 31
ES - Italia 29
EC - Ecuador 28
TR - Turchia 27
AT - Austria 25
BE - Belgio 23
ZA - Sudafrica 22
UZ - Uzbekistan 21
AU - Australia 20
PH - Filippine 20
SA - Arabia Saudita 20
PL - Polonia 19
IL - Israele 17
KH - Cambogia 17
CL - Cile 16
JO - Giordania 15
NP - Nepal 14
KE - Kenya 13
KZ - Kazakistan 13
EG - Egitto 12
MU - Mauritius 12
MY - Malesia 12
TN - Tunisia 11
DZ - Algeria 10
IE - Irlanda 10
AZ - Azerbaigian 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
LB - Libano 8
PY - Paraguay 8
TH - Thailandia 8
LT - Lituania 7
HU - Ungheria 6
NG - Nigeria 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
PS - Palestinian Territory 5
SN - Senegal 5
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
TW - Taiwan 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
JM - Giamaica 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
IR - Iran 2
KW - Kuwait 2
LK - Sri Lanka 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
Totale 175.765
Salva come PNG Salva come JPEG
Città #
Cagliari 145.657
Uta 5.881
Fairfield 1.226
Singapore 1.166
Ashburn 1.090
Woodbridge 1.039
Houston 1.037
Chandler 978
Boardman 738
San Jose 716
Dallas 644
Ann Arbor 538
Wilmington 522
Jacksonville 519
Seattle 500
Cambridge 465
Nyköping 353
Beijing 248
Los Angeles 243
Hong Kong 241
Hefei 232
Helsinki 231
Nanjing 187
Boston 178
Lauterbourg 168
The Dalles 160
Santa Clara 141
Council Bluffs 131
Dearborn 131
Ho Chi Minh City 131
Buffalo 118
Seoul 117
Hanoi 108
San Diego 102
Shanghai 91
Milan 86
Dong Ket 66
Nanchang 57
Mountain View 56
Shenyang 56
Redwood City 52
Verona 52
Jiaxing 49
Tianjin 49
London 48
Guangzhou 46
São Paulo 46
Ferrara 45
Rome 44
New York 43
Changsha 40
Chicago 40
Pune 40
Frankfurt am Main 39
Washington 39
Hebei 38
Falls Church 35
Norwalk 34
Toronto 30
Sassari 28
Tokyo 28
Paris 27
Jinan 26
Orange 26
Columbus 25
Phoenix 24
Redondo Beach 24
Orem 23
Brooklyn 21
Ningbo 21
Saint Petersburg 21
Belo Horizonte 20
Tashkent 20
Baghdad 19
Rio de Janeiro 19
Nuremberg 18
Atlanta 17
Haiphong 17
Mexico City 17
Olbia 17
Phnom Penh 17
Brussels 16
Munich 16
Canberra 15
San Francisco 15
Zhengzhou 15
Amman 14
Casablanca 14
Jakarta 14
Hyderabad 13
Lahore 13
Tappahannock 13
Brasília 12
Chennai 12
Da Nang 12
Hangzhou 12
Quito 12
Warsaw 12
Auburn Hills 11
Biên Hòa 11
Totale 167.884
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 2.905
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.855
Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors 2.837
Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain 2.804
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.731
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.707
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.662
DIHYDROQUINAZOLINE BENZYLAMIDES AS ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORS 2.600
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.597
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW DNA METHYLTRANSFERASE INHIBITORS 2.584
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.523
Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment 2.482
Critical role for prokineticin 2 in CNS autoimmunity 2.458
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.367
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes 2.302
Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity 2.279
Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones 2.269
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.249
Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy 2.207
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation 2.203
Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo 2.097
Synthesis and evaluation of antioxidant and antiproliferative activity of 2-arylbenzimidazoles 2.074
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy 2.062
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 2.050
In-Vitro Evaluation of Antioxidant, Antiproliferative and Photo-Protective Activities of Benzimidazolehydrazone Derivatives 2.007
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.897
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice 1.867
An important role for prokineticin 2 in autoimmune CNS demyelination 1.812
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.789
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors 1.769
null 1.768
δ-Opioid Receptor Activation Attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel Mechanism of Neuroprotection Against Parkinsonian Injury 1.652
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 1.640
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease 1.584
Genetically Encodable Bacterial Flavin Transferase for Fluorogenic Protein Modification in Mammalian Cells 1.582
Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated 1.555
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors 1.517
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 1.481
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 1.460
Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior 1.401
null 1.383
Antagonism of EG-VEGF receptors is a novel targeted therapy for choriocarcinoma progression: in vitro, in vivo and in clinical studies 1.369
Ligand- and cell-dependent determinants and cAMP modulation by delta opioid receptor (DOR) agonists 1.351
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.349
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors 1.328
A novel mechanism for cytoprotection against hypoxic injury: delta-opioid receptor-mediated increase in Nrf2 translocation 1.311
The antagonism of the prokineticin system counteracts bortezomib induced side effects: Focus on mood alterations 1.280
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 1.279
Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes 1.266
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.228
Prokineticin 1-prokineticin receptor 1 signaling promotes angiogenesis in the porcine endometrium during pregnancy 1.174
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.167
∂-opioid receptor activation protects against Parkinson’s disease-related mitochondrial dysfunction by enhancing PINK1/Parkin-dependent mitophagy 1.153
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals 1.092
Opposite Roles of δ- and μ-Opioid Receptors in BACE1 Regulation and Alzheimer’s Injury 1.092
Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during Pregnancy 1.053
Antidepressant-like and anxiolytic-like effects following activation of the mu-delta opioid receptor heteromer in the nucleus accumbens 956
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 908
δ‐Opioid receptors up‐regulate excitatory amino acid transporters in mouse astrocytes 869
Delta-opioid receptor activation modified microRNA expression in the rat kidney under prolonged hypoxia 865
Effect of delta-opioid receptor activation on BDNF-TrkB vs. TNF-Alpha in the mouse cortex exposed to prolonged hypoxia 852
activation of the mu-delta opioid receptor heteromer produces anti-depressant-like and anxiolytic-like effects 850
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 841
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 829
null 825
New features of the delta opioid receptor: conformationalproperties of deltorphin I analogues 815
Agonists at the delta-opioid receptor modify the binding of mu-receptor agonists to the mu-delta receptor hetero-oligomer 808
Prokineticin receptors antagonist PC-10 as a biomarker for imaging inflammatory pain 808
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 807
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis 740
null 731
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis 730
Conformational dynamics of KIR3.1/KIR3.2 channel activation via delta-opioid receptors (DORs) 730
Structural and biological exploration of Phe3-Phe4-modified endomorphin-2 peptidomimetics 725
Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors 724
Hair Growth Promotion by δ-Opioid Receptor Activation 715
Hydrogen sulfide inhibits inflammatory pain and enhances the analgesic properties of delta opioid receptors 697
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues. 680
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 679
DOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortex 679
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore 653
Na+ mechanism of delta-opioid receptor induced protection from K+ leakage in the cortex 633
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues 633
Role of the 2',6'-dimethyl-L-tyrosine (Dmt) in some opioid lead compounds 627
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist, correlation between desensitization and tolerance 626
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 626
Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model 613
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors 609
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain 603
Structure-activity relatioships of tetrapeptides related to dermorphin: a 500-MHz 1H-nmr study 580
A Critical Role of δ-Opioid Receptor in Anti-microglial Activation Under Stress 574
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 557
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 557
Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice 555
Hydrogen Sulfide Increases the Analgesic Effects of µ- and δ-Opioid Receptors during Neuropathic Pain: Pathways Implicated 554
null 546
Prokineticin 1 is a novel factor regulating porcine corpus luteum function 536
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism 536
Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides 532
Synthesis of N-FmocN,N'-bis-Boc-5-,6- and 8-guanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid (5-GTIC, 6-GTIC and 8-GTIC) 531
Totale 136.104
Salva come PNG Salva come JPEG
Categoria #
all - tutte 253.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 253.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.264 0 0 0 0 0 0 0 0 0 0 1.745 1.519
2021/20229.546 600 806 1.092 529 420 819 912 643 595 587 934 1.609
2022/202316.522 1.658 1.741 1.164 1.262 1.464 2.157 1.168 1.527 978 1.019 1.601 783
2023/202419.214 725 818 712 1.288 1.898 3.050 3.230 1.222 924 1.297 1.763 2.287
2024/202539.798 8.850 11.727 5.060 4.256 2.362 2.242 3.438 216 421 314 361 551
2025/20269.604 606 578 1.421 759 666 648 1.493 818 936 1.656 23 0
Totale 176.374